Ph.D., CEO, Cofactor Genomics
Dr. Jarret Glasscock received his Phd in Molecular Genetics/Computational Biology from Washington University while working on The Human Genome project under Warren Gish. Prior to that, he studied at University of Arizona where he received a BS in Molecular Biology with a Computer Science emphasis. Jarret led the Computational Biology group at The Genome Institute and was part of the Technology Development team prior to co-founding Cofactor Genomics. Today Jarret is the CEO of Cofactor Genomics, a company focused on developing RNA-based technologies that enable a new generation of diagnostics to make personalized medicine a reality. Jarret has been covered by Genetic Engineering News (GEN), Tech Crunch, and Wired Magazine. He is a member of the Personalized Medicine Coalition, International Society for Computational Biology, and is a Y Combinator Alum.
Presentation Title and Company Description
AI and Data Science Showcase: RNA, Machine Learning, and Immune Oncology
Cofactor Genomics is a leader in developing tools to interrogate RNA. Cofactor’s CAP-CLIA RNA-seq based tumor profiling diagnostics leverage molecular technologies and machine learning to characterize both the tumor and tumor micro-environment.